Table 3.
Organism | Antibiotics | MRI;% | |
---|---|---|---|
Sensitivea to | Resistant to | ||
Arizona sp. | Cf(32), B(11), E(15), T(17), Tr(25), G(21), Nx(32), Gf(29), Pb(10) | P, Va, A, Ce, Cb | 35.7 |
Bacillus sp. | Cf(17), Va(17), T(24),G(12), Nx(25), Gf(27), Pb(11) | P, B, A,Ce, E, Tr, Cb | 50.0 |
Enterobacter sp. | Cf(33),Va(15), E(18), T(20), G(17), Nx(23), Gf(22), Pb(12) | P, B, A, Ce, Tr, | 42.8 |
Enterococcus sp. | Cf(33), B(9), Ce(11), E(12), T(15), Tr(22), Nx(27), Gf(24), Pb(12) | P, Va, A, G, Cb | 30.8 |
Escherichia coli | Cf(29), B (9), Va(10), Ce(19), E(16), T(21), Tr(25), G(13), Nx(26), Gf(27), Pb(11) | P, A, Cb | 15.4 |
Klebsiella sp. | Ce(17), E(16),T(20), Tr(24), G(18), Nx(15), Gf(23), Pb(11) | P, B, Va, A, Cb | 30.8 |
Micrococcus tetragens | Pb(14) | Cf, B, Va, A, Ce, E, T, Tr, G, Nx, Gf, Cb, P | 92.3 |
Salmonella paratyphi | Ce(12), E(14), T(28), G(22) | P, Cf, B, Va, A, Tr, Nx, Gf, Pb, Cb | 71.4 |
Shigella dysenteriae | Cf(40), T(20), G(24), Nx(34), Gf(40), Pb(16) | P, B, Va, A, Ce, E, Tr, Cb | 57.1 |
Staphylococcus sp. | Cf(12), B(9), Va(15), E(27), T(17), Tr(21), G(23), Nx(18), Gf(25), Pb(11), | A, Ce, Cb | 23.1 |
Vibrio sp. | Cf(34), Va(12), E(17), T(18), Tr(28), G(21), Nx(21), Gf(22), Pb(10) | P, B, A, Ce, Cb | 38.5 |
aValues in parentheses represent zone of sensitivity in mm; MRI Multiple Antibiotic Resistance Index; A Ampicillin; B Bacitracin; Cb Carbencillin;
Ce Cefotaxime; Cf Ciprofloxacin; E Erythromycin; G Gentamycin; Gf Gatifloxacin; Nx Norfloxacin; P Penicillin; Pb Polymyxin B; T Tetracycline; Tr Trimethoprim, Va Vancomycin